Analysis of expressed and non-expressed IGK locus rearrangements in chronic lymphocytic leukemia

被引:11
作者
Belessi, C
Stamatopoulos, K
Hadzidimitriou, A
Hatzi, K
Smilevska, T
Stavroyianni, N
Marantidou, F
Paterakis, G
Fassas, A
Anagnostopoulos, A
Laoutaris, N
机构
[1] Nikea Gen Hosp, Dept Hematol, Piraeus, Greece
[2] G Papanicolaou Hosp, Dept Hematol, Thessaloniki, Greece
[3] G Papanicolaou Hosp, Hematopoiet Cell Transplantat Unit, Thessaloniki, Greece
[4] G Gennimatas Hosp, Dept Immunol, Athens, Greece
关键词
D O I
10.2119/2005-00044.Belessi
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Immunoglobulin kappa (IGK) locus rearrangements were analyzed in parallel on cDNA/genomic DNA in 188 kappa- and 103 lambda-chronic lymphocytic leukemia (CLL) cases. IGKV-KDE and IGKJ-C-intron-KDE rearrangements were also analyzed on genomic DNA. In kappa-CLL, only 3 of 188 cases carried double in-frame IGKV-J transcripts: in such cases, the possibility that leukemic cells expressed more than one K chain cannot be excluded. Twenty-eight kappa-CLL cases also carried nonexpressed (nontranscribed and/or out-of-frame) IGKV-J rearrangements. Taking IGKV-J, IGKV-KDE, and IGKJ-C-intron-KDE rearrangements together, 38% of kappa-CLL cases carried biallelic IGK locus rearrangements. In lambda-CLL, 69 IGKV-J rearrangements were detected in 64 of 103 cases (62%); 24 rearrangements (38.2%) were in-frame. Four cases carried in-frame IGKV-J transcripts but retained monotypic light-chain expression, suggesting posttranscriptional regulation of allelic exclusion. In all, taking IGKV-J, IGKV-KDE, and IGKJ-C-intron-KDE rearrangements together, 97% of lambda-CLL cases had at least 1 rearranged IGK allele, in keeping with normal cells. IG repertoire comparisons in kappa- versus lambda-CLL revealed that CLL precursor cells tried many rearrangements on the some IGK allele before they become lambda producers. Thirteen of 28 and 26 of 69 non-expressed sequences in, respectively, kappa- or lambda-CLL had < 100% homology to germline. This finding might be considered as evidence for secondary rearrangements occurring after the onset of somatic hypermutation, at least in some cases. The inactivation of potentially functional IGKV-J joints by secondary rearrangements indicates active receptor editing in CLL and provides further evidence for the role of antigen in CLL immunopathogenesis.
引用
收藏
页码:52 / 58
页数:7
相关论文
共 81 条
[1]   Autoreactivity by design: Innate B and T lymphocytes [J].
Bendelac, A ;
Bonneville, M ;
Kearney, JF .
NATURE REVIEWS IMMUNOLOGY, 2001, 1 (03) :177-186
[2]   Transcript expression of two Igλ rearrangements and RAG-1/RAG-2 in a mature human B cell producing IgMλ islet cell autoantibody [J].
Benito, C ;
Gomis, R ;
Fernández-Alvarez, J ;
Usac, EF ;
Gallart, T .
JOURNAL OF CLINICAL IMMUNOLOGY, 2003, 23 (02) :107-118
[3]  
BORCHE L, 1990, BLOOD, V76, P562
[4]  
Bräuninger A, 2001, EUR J IMMUNOL, V31, P3631
[5]   CHRONIC LYMPHOCYTIC LEUKEMIC (CLL) CELLS SECRETE MULTISPECIFIC AUTOANTIBODIES [J].
BROKER, BM ;
KLAJMAN, A ;
YOUINOU, P ;
JOUQUAN, J ;
WORMAN, CP ;
MURPHY, J ;
MACKENZIE, L ;
QUARTEYPAPAFIO, R ;
BLASCHEK, M ;
COLLINS, P ;
LAL, S ;
LYDYARD, PM .
JOURNAL OF AUTOIMMUNITY, 1988, 1 (05) :469-481
[6]   Efficient downregulation of immunoglobulin μ mRNA with premature translation-termination codons requires the 5′-half of the VDJ exon [J].
Bühler, M ;
Paillusson, A ;
Mühlemann, O .
NUCLEIC ACIDS RESEARCH, 2004, 32 (11) :3304-3315
[7]   Contribution of receptor editing to the antibody repertoire [J].
Casellas, R ;
Shih, TAY ;
Kleinewietfeld, M ;
Rakonjac, J ;
Nemazee, D ;
Rajewsky, K ;
Nussenzweig, MC .
SCIENCE, 2001, 291 (5508) :1541-1544
[8]   Immunoglobulin heavy chain gene replacement: A mechanism of receptor editing [J].
Chen, C ;
Nagy, Z ;
Prak, EL ;
Weigert, M .
IMMUNITY, 1995, 3 (06) :747-755
[9]   Editing disease-associated autoantibodies [J].
Chen, C ;
Prak, EL ;
Weigert, M .
IMMUNITY, 1997, 6 (01) :97-105
[10]   National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: Revised guidelines for diagnosis and treatment [J].
Cheson, BD ;
Bennett, JM ;
Grever, M ;
Kay, N ;
Keating, MJ ;
OBrien, S ;
Rai, KR .
BLOOD, 1996, 87 (12) :4990-4997